Yamamoto N, Koyama T, Sato J, Yoshida T, et al. Phase I study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in Japanese patients with advanced or metastatic solid tumors. Cancer Chemother Pharmacol 2024;94:109-115.
PMID: 38206370